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Abstract: The mechanisms of chronic infections caused by opportunistic pathogens are of 
keen  interest  to  both  researchers  and  health  professionals  globally.  Typically,  chronic 
infectious disease can be characterized by an elevation in immune response, a process that 
can often lead to further destruction. Reactive-Oxygen-Species (ROS) have been strongly 
implicated in the aforementioned detrimental response by host that results in self-damage. 
Unlike excessive ROS production resulting in robust cellular death typically induced by 
acute  infection  or  inflammation,  lower  levels  of  ROS  produced  by  host  cells  are 
increasingly  recognized  to  play  a  critical  physiological role  for  regulating  a  variety  of 
homeostatic cellular functions including growth, apoptosis, immune response, and microbial 
colonization.  Sources  of  cellular  ROS  stimulation  can  include  “danger-signal-molecules” 
such  as  extracellular  ATP  (eATP)  released  by  stressed,  infected,  or  dying  cells. 
Particularly, eATP-P2X7 receptor mediated ROS production has been lately found to be a 
key  modulator  for  controlling  chronic  infection  and  inflammation.  There  is  growing 
evidence  that  persistent  microbes  can  alter  host  cell  ROS  production  and  modulate  
eATP-induced ROS for maintaining long-term carriage. Though these processes have yet 
to be fully understood, exploring potential positive traits of these “injurious” molecules 
could illuminate how opportunistic pathogens maintain persistence through physiological 
regulation of ROS signaling. 
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1. Introduction 
One  of  the  early  responses  of  host  innate  immunity  is  the  Reactive-Oxygen-Species  (ROS) 
production in reaction to microbial invaders. Free oxygen radicals are highly toxic to pathogens and 
are utilized as a tool to prevent colonization of tissues by microorganisms. ROS are also a key part of 
the intracellular redox profile influencing a wide variety of signaling networks [1]. Therefore, the 
relatively high-level of oxidants, as seen in respiratory burst or low-levels in normal tissue, is likely a 
significant aspect of cell physiology during infection. Oxidative stress occurs when oxygen radical 
formation  and  levels  exceed  those  of  antioxidants,  potentiating  cell  responses  such  as  apoptosis, 
tumorgenesis, and immune-response [1–3]. However, the necessity of ROS for immune function could 
be  exploited  by  “potential  pathogens”  to  reduce  host  responses  in  order  to  enhance  survival  and 
colonization  in  their  target  host  cells.  Consistent  with  this  view,  characterization  of  molecular 
circuitries between the cellular ROS and a host derived small-danger-molecule “extracellular ATP” 
(eATP), which has lately been recognized as an important physiological signaling mediator that can 
convert opportunistic microbes into pro-inflammatory pathogens or provide long-term persistence for 
disease causing pathogens, is of great interest to current research [4,5]. Accordingly, we will first 
provide a general overview of recent literature on the mechanisms of production of cellular ROS and 
its  role  in  establishment  of  microbes  in  host  tissues.  Then,  we  will  present  the  novel  subject  of 
purinergic eATP and  P2X7 coupling mediated cellular ROS and its significance for the microbial 
persistence and inflammation through examples that have recently become apparent. 
2. Cellular ROS and Its Implications for Microbial Infections 
ROS molecules participate in multi-faceted activities within cells, acting as secondary signaling 
molecules  for  inflammation  and  immune  responses,  in  addition  to  directly  harming  microbes  that 
invade tissues [6]. As a hallmark of innate immunity, it is important to understand the necessity of 
ROS signaling for host responses to challenges presented by microbial invasion. Efficient clearance of 
colonizing microorganisms is highly dependent on ROS, thus exploration of the mechanisms between 
oxygen  radicals  and  innate  immune  responses  associated  with  pathogen  clearance  has  been  an 
intriguing topic for researchers.  
2.1. Sources of Intracellular ROS Production as an Early Response 
It is well known that ROS production is rapidly elevated during infection, serving to facilitate 
pathogen  clearance  as  well  as  contributing  to  signaling  cascades  related  to  inflammation,  cell 
proliferation, and immune responses [7]. Two of the best characterized sources of ROS during host 
cell-  microbe  interactions  are  the  membrane  associated  NADPH  oxidase  complex  and  the 
mitochondrial  electron  transport  chain  (Mt-ETC).  The  Mt-ETC  transiently  produces  radicals  as Int. J. Mol. Sci. 2011, 12                       
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electrons move between the complexes, primarily at Complexes I [8,9] and III [9] and these play key 
roles in activation of innate immunity.  
The connection between innate immune responses, mitochondrial-ROS and microbial infection has 
been  unclear  in the past.  Recent evidence suggests that a Nucleotide-Binding  domain (NBD)  and 
Leucine-Rich  Repeat  (LRR)-containing  family  member  receptor  (NLR),  NLRX1,  may  provide  an 
answer  to  this  elusive  question.  NLRs,  also  well  known  as  Nod-like  receptors,  are  intracellular 
pathogen-associated molecular pattern (PAMPs) receptors, which serve to alert the cell to the presence 
of intracellular invaders. Though there are many NLRs, only one of these localizes to the mitochondria 
to  facilitate  innate  immune  responses,  NLRX1  [10,11].  NLRX1  stimulates  production  of  ROS 
molecules, which in turn can directly interact with the pathogen as well as act as a secondary signaling 
molecule [12–14]. Originally identified to utilize the mitochondrion as a platform to mediate antiviral 
responses [11], NLRX1 now appears to also be important for immune responses to bacterial infections 
as  well.  Knowledge  of  bacterial-mitochondrial  interactions  are  limited,  however,  a  recent  review 
provides  a  comprehensive  overview  of  bacterial  influences  upon  the  mitochondrion,  including 
NLRX1 [15]. NLRX1-induced ROS appears to be critical for bacterial infections, especially in terms 
of its signaling properties. A study performed using  Shigella-infected and tumor necrosis factor-α 
(TNF-α)-primed cells showed that NLRX1 mediated ROS formation [16]. The downstream result of 
the  elevated  ROS  levels  in  this  particular  study  was  enhanced  NF-κB  and  Jun  amino-terminal  
kinases-dependent (JNK) signaling, demonstrating the role for ROS as a secondary messenger for  
pro-inflammatory gene transcription and cytokine-based signal responses during infection. Another 
new study also provided evidence for the key role ROS-mediated signaling can have during infection. 
This group’s efforts showed that NLRX1 enhanced mitochondrial-derived ROS formation in response 
to Chlamydial infection [17]. Though only a small amount of evidence supports the importance of 
NLRX1-mediated ROS production during infection, this is most likely due to the recent idea that 
NLRX1 could be an important mediator of mitochondrial-ROS production during infections. Much 
like the mitochondria, NADPH oxidase is a primary site for generation of ROS molecules during 
microbial infection of host cells [18]. 
NADPH oxidase complexes are common sources of ROS typically associated with rapid respiratory 
burst mechanisms of professional phagocytic cells, and carry out the electron transferring reaction 
from NADPH to molecular oxygen (O2) in the membranes of phagosomes, endosomes, and the cell 
membrane [19]. The studies lately have shown the functionally active NADPH oxidase machinery in 
various  cells  types  including  epithelial  and  endothelial  cells  [20,21].  NADPH  oxidase  protein 
complexes consist of several phox subunits; the cytosolic p40, p47, and p67 in addition to p22 and 
gp91,  which  localize  to  the  membrane.  The  latter  two  phox  subunits,  p22  and  gp91,  make  up 
flavocytochrome b558, the catalytic, superoxide-generating core of NADPH oxidase [22]. A type of 
Rho-GTPase, called Rac, also associates with the complex  [19,22] and mediates NADPH oxidase 
activity  [19,23]  and  downstream  inflammatory  signaling  processes  [24].  Certain  regulatory 
mechanisms are in place to control NADPH oxidase activity, including proteins and wide-sweeping 
signaling cascades.  Control of Rac falls  to  the Rho-GDP  dissociation inhibitor (Rho-GDI), which 
translocates  Rac  from  the  membrane  to  the  cytoplasm,  effectively  deactivating  NADPH  
oxidase  [25,26].  Phosphoinositide-3  kinases  (PI3Ks)  also  manage  the  NADPH  oxidase  complex 
through the  modulation of Rac activity and  direct binding of the p40/47  subunits  [27]. Thus, the Int. J. Mol. Sci. 2011, 12                       
 
 
337 
powerful  induction  of  ROS  and  inflammatory  signaling  cascades  by  NADPH  oxidase  are  under 
multiple  levels  of  control,  likely  to  ensure  faithful  activation  of  the  complex  and  its  downstream 
signaling intermediates. NADPH oxidase activation is vital for management of microbial invasion, but 
the precise mechanisms linking activation of the complex with elimination of microorganisms has been 
not completely characterized. A recent study of LyGDI (a monocyte-specific Rho-GDI [25])  may 
provide  valuable  insight  into  the  underlying  molecular  mechanisms  mediating  NADPH  oxidase 
activity  in  response  to  phagocytosis  of  microbes.  LyGDI  was  shown  to  associate  with  
caspase-recruiting  domain-containing  protein  9  (CARD9)  at  phagosomes  harboring  Listeria 
monocytogenes in macrophages [28]. The interaction between CARD9 and LyGDI allowed Rac to 
associate with the other NADPH oxidase components, thereby providing the activating signal for ROS 
production  by  NADPH  oxidase.  Identifying  potential  mechanisms  for  immune  response  element 
activation,  such  as  CARD9-lyGDI  association,  could  be  crucial  to  understanding  host  immunity 
against microbial invasion. 
Thus, the highly regulated NADPH oxidase is a potent contributor to resistance against infection by 
microorganisms. Due to the key role of NADPH oxidase for participating in immunity, it seems logical 
that it should be a target for microbial intervention. In actuality, microbes can subvert NADPH oxidase 
through direct interactions with the phox subunits and Rac. Additionally, mitochondrial-based ROS 
production can function to eliminate microorganisms. Much like NADPH oxidase, the mitochondrion 
appears to be a target for microbial interference. We will now provide examples of microbes demonstrated 
to modulate mitochondrial and NADPH oxidase-induced ROS to mediate immune evasion. 
2.2. Modulation of Intracellular ROS by Infection 
Immune cells depend on ROS to not only kill phagocytosed microorganisms, but also to mediate 
inflammatory and immune signaling cascades. There is direct evidence that a wide variety of microbes 
can  limit  ROS,  thus  increasing  the  potential  for  persistent  infection  [29].  This  novel  strategy  to 
promote microbial survival within the hostile host environment appears to be primarily the result of 
NADPH oxidase and mitochondrial-derived ROS modulation.  
Many bacteria directly interfere with accumulation of ROS molecules via prevention of NADPH 
oxidase assembly. Francisella tularensis live vaccine strain was shown to not only escape neutrophil 
phagosomes, but also directly prevented NADPH oxidase assembly during intracellular infection [30]. 
This bacterium specifically prevented recruitment of gp91
phox/p22
phox and p47/p67
phox subunits to the 
phagosome,  thereby  attenuating  the  oxidative  burst  mechanism  utilized  by  neutrophils.  Another 
bacterium,  Anaplasma  phagocytophilum,  prevents  p22  and  gp91  incorporation  into  phagosomes 
containing the microbe, thus attenuating NADPH oxidase activity [31,32]. It is also suggested that 
A. phagocytophilum also directly scavenges ROS, providing an additional defense mechanism against 
oxygen radical-based host immunity [31]. 
A  study  of  Chlamydia  trachomatis,  a  bacterial  pathogen  associated  with  urogenital  infections, 
demonstrated that the rapid induction of ROS within macrophages could be attenuated over a period of 
time [33]. This was shown to be accomplished by incorporation of the Rac subunit of NADPH oxidase 
to the Chlamydia-containing vacuole, thus inhibiting oxidative burst. The most important observation 
of  this  study,  however,  is  that  Chlamydia  can  alter the intracellular ROS  content  back  to  normal Int. J. Mol. Sci. 2011, 12                       
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steady-state  conditions  [33].  By  returning  ROS  levels  to  normal,  as  seen  in  uninfected  cells,  the 
Chlamydia  essentially  masks  its  presence  by  altering  a  key  immune  sensor  and  inflammation 
activating mechanism.  
The ability to inhibit recruitment of NADPH oxidase subunits appears to be a common theme for 
many other pathogens, including Legionella pneumophila and Coxiella burnetii. C. burnetii, which is 
known to cause chronic Q fever in livestock and humans, prevents recruitment of p47/p67 to the 
phagosome  and  thus  limits  respiratory  burst  within  infected  neutrophils  [34].  Prevention  of  p47 
recruitment is also a facet of Legionella infection of macrophage-like cells [35]. Despite the fact that a 
strong majority of literature introducing this strategy involves hematopoietic-cell lineages, there is 
evidence supporting NADPH oxidase assembly interference during infection of other tissue types. For 
example,  Bacillus  anthracis  edema  toxin  has  been  implicated  in  prevention  of  NADPH  oxidase 
activity [36]. This was shown to be achieved through Protein Kinase A-mediated phosphorylation of 
the NADPH oxidase component p67, in intestinal epithelium [36]. 
Extracellular  microorganisms  also  possess  the  ability  to  alter  intracellular  ROS  production, 
contributing  to  persistence  of  infection.  Burkholderia  cenocepacia  are  opportunistic  pathogens 
implicated in chronic inflammatory conditions including Cystic Fibrosis (CF). These bacteria have 
been  demonstrated  to  inhibit  ROS  production  in  infected  neutrophils,  primarily  through 
exopolysaccharide  formation  [37].  In  addition  to  interfering  with  neutrophil  chemotaxis,  the 
exopolysaccharides demonstrated the ability to directly scavenge free oxygen radicals, regardless of 
their intracellular origination. B. cenocepacia also has been shown to exist in macrophage vacuoles 
with  delayed  NADPH  oxidase  incorporation,  suggesting  that  it  can  persist  within  host  cells  by 
prevention  of  NADPH  oxidase  components  and  oxidative  burst  [38].  In  another  opportunistic 
bacterium  associated  with  CF,  Pseudomonas  aeruginosa,  secondary  metabolite  production  by  the 
pathogen  has  been  shown  to  interfere  with  phagocytic  engulfment  of  apoptotic  cells  [39].  This 
secondary metabolite, pyocyanin, mediates this process by reducing intracellular ROS levels and Rho 
GTPase activities in host cells, likely leading to enhanced inflammation at sites of infection due to 
failure to phagocytose dying cells [39]. 
Neisseria gonorrhoeae is known to suppress oxidative bursts in neutrophils [40]. This observation 
was not observed for nonviable N. gonorrhoeae, suggesting that live cell metabolic activity directly 
relates to suppression of oxidative burst. Though this study did not attempt to identify potential targets 
for inhibition of NADPH oxidase ROS, the observed reduction in  oxygen  radical  production was 
shown to be dependent upon contact between the host cells and the metabolically active bacteria [40]. 
Candida albicans, an opportunistic fungal pathogen of humans, has the ability to suppress ROS 
production in host immune cells [41]. The precise mechanism utilized by C. albicans remains unclear, 
but a recent study presented findings indicating that the microorganism is capable of overcoming  
auto-induction  of  ROS,  resulting  in  suppressed  oxygen  radical  formation  [41].  Another  fungal 
pathogen, Aspergillus fumigatus, has been shown to limit ROS production in neutrophils [42,43]. 
Unlike the previously described organisms, Entamoeba histolytica, potentiates NADPH oxidase 
ROS  accumulation  in  host  cells,  resulting  in  apoptosis  [44].  This  parasite  utilizes  the  secondary 
signaling  properties  of  NADPH  oxidase-derived  ROS  molecules  to  influence  Extracellular  
signal-Related Kinase (ERK) 1/2 signaling, eventually stimulating host cell death. Though typically 
associated with cell survival and proliferation, there is documented evidence supporting the potential Int. J. Mol. Sci. 2011, 12                       
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for  ERK1/2  to  induce  cell  death  [45–47].  Infection  of  host  cells  by  two  other  pathogens,  
Trypanosoma cruzi, the causative agent of Chagas’ disease, and Japanese encephalitis virus (JEV), 
also results in enhanced ROS formation. These two pathogens also utilize enhanced ROS to induce 
host cell death, thus allowing escape and likely contributing to spread of the pathogens through the 
apoptotic bodies. 
JEV  infection  of  promonocytic  cells  resulted  in  host  cell  apoptosis  mediated  by  intracellular 
accumulation  of  ROS  and  activation  of  pro-apoptotic  signaling  [48].  Destruction  of  host  cells  by  
virus-induced ROS production could facilitate persistence of viral infection by enhancing the spread of 
virions. T. cruzi can infect humans and lie dormant, only to reemerge and cause chronic inflammatory 
destruction  of  organs.  Interestingly,  a  recent  study  demonstrated  that  T.  cruzi-induced  ROS 
accumulation  did  not  involve  NADPH  oxidase  [49].  Further  analysis  in  this  report  showed  that 
enhanced  ROS  formation  occurred  due  to  pathogen-mediated  mitochondrial  membrane  potential 
perturbation. Though this was not the first suggestion that T. cruzi optimizes infection and persistence 
through mitochondrial ROS accumulation and oxidative stress [50], this study does demonstrate the 
current  level  of  interest  that  researchers  have  in  regards  to  understanding  microbial-mediated 
influences on ROS production.  
Possession of the High Pathogenicity Island (HPI), encoding yersiniabactin, appears to play a role 
for pathogenesis of Yersinia and members of Enterobacteriaceae. A new study suggests that due to the 
iron-scavenging nature of yersiniabactin, it could provide a novel way to inhibit ROS formation by 
preventing the Haber-Weiss hydroxyl-radical-forming reaction in infected host cells [51]. Though this 
may  be  an  indirect  method  to  limit  pathogen  clearance  by  host  cells,  it  is  evident  that  bacteria 
possessing HPI display enhanced pathogenesis [51]. Additional Yersinia-related virulence factors have 
been  extensively  studied  [52–55].  However,  more  detail  studies  are  required  to  fully  characterize 
Yersinia-directed ROS inhibition, especially for determining the sources of mechanisms providing the 
ROS regulation. 
Modulation of ROS levels appears to be a conserved strategy utilized by various microorganisms. 
Induction  or  inhibition  of  oxygen  radicals  could  facilitate  enhanced  colonization,  via  reduced  
ROS-mediated  host  responses  to  infection.  Additionally,  regulation  of  cellular  ROS  by 
microorganisms can play a critical role in chronic inflammatory diseases and cancer. We will now 
focus on our main interest of signaling molecules, eATP and its putative receptor P2X7 generated ROS 
and  the  evidence  for  microbial  modulation  of  this  pathway  to  enhance  microbial  survival  and 
persistence in host tissues. 
3. eATP-P2X7 Receptor Signaling in Controlling Infection and Inflammation via Cellular ROS 
3.1. eATP as a “Danger Signal” 
Adenosine-5’-triphosphate,  ATP,  is  a  nucleotide  molecule  utilized  for  a  variety  of  processes, 
including cellular metabolism and signaling. ATP can be released into the extracellular environment 
by cells under normal conditions as well as a result of cellular stress, infection or cell death. Once 
outside of the cell, it is identified as extracellular ATP. eATP has become well recognized for its role 
as a “danger signal” for immune activation [56,57]. Effect of eATP is carried out via stimulation of Int. J. Mol. Sci. 2011, 12                       
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cellular purinergic receptors and their associated signaling processes. Lately, this host-cell derived 
small molecule induced responses have become a key topic for researchers studying the pathogenic 
nature of a wide variety of microorganisms. This may represent a novel target for pathogen-mediated 
subversion of the host immune response.  
The evidence supporting the role of eATP as a potent activator in innate immunity is quite large. 
Pro-inflammatory  cytokine  production  and  secretion  is  a  well  characterized  event  in  numerous 
pathologies, and ATP clearly has a role in initiating these events. For example, eATP has been shown 
to elicit transcription of IL-6 in macrophages [58]. IL-6 plays an important role in phagocytic cell 
responses  of  innate  immunity,  primarily  serving  as  a  mediator  of  macrophage  development  from 
monocytic cells [59]. IL-6 stimulation of monocytes also suppresses dendritic cell (DC) formation, 
suggesting eATP may perform antagonistic roles in immunity, possibly in immunotolerance [60]. It 
should also be noted, that eATP has been implicated in maintenance of lung airway inflammation via 
DC  activation  [61],  thus  demonstrating  the  complex  nature  of  eATP-mediated  processes  (For  a 
detailed  review  regarding  multifaceted  capabilities  of  ATP  on  various  cell  types,  readers  should 
see [56] for more information). eATP is also involved in production of the inflammatory cytokine  
IL-1β,  a  participant  in  the  regulation  of  cell  differentiation,  death,  and  inflammation.  A  study 
performed in 1998 characterized eATP-induced release of IL-1β from LPS-primed monocytes, while 
also confirming that this process was dependent on the purinergic P2X7 receptor [62]. It also appears 
that in other cell models, such as fetal astrocytes, IL-1β-mediated transcription factor expression is 
linked with ATP and P2 receptor signaling [63,64]. Elevated Nuclear Factor-kappaB (NF-κB) and 
activator  protein-1  (AP-1)  expression  were  seen  when  astrocytes  were  stimulated  with  eATP, 
suggesting a role for purinergic signaling in nervous system inflammatory pathologies [64].  
Acting  as  a  sensor  for  pathogens,  the  inflammasome  promotes  pro-inflammatory  cytokine 
production, a process dependent upon generation of ROS. The inflammasome is a critical component 
of the innate immune system and facilitates heightened immune activities against pathogenic invaders, 
such as Chlamydia [65]. The inflammasome consists of Apoptosis-associated speck protein (ASC), 
caspase-1 and NLR3, NOD-like receptor protein 3 [66]. Cleavage of immature pro-IL-1β by capsase-1, 
results in mature IL-1β formation [67]. Acting as a secondary signaling molecule, ROS are required 
for NALP3 inflammasome formation [66] and recent studies demonstrate the necessity of ROS to 
mediate  this  process  [43].  Furthermore,  the  processing  of  IL-1β  in  P.  gingivalis-infected  primary 
gingival  epithelial  cells  was  shown  to  require  eATP  stimulation  via  P2X7  receptor  coupling  for 
cytokine release [68]. This could imply that not only can eATP provide a pro-inflammatory stimulus to 
cells, but it can also directly influence final processing and release of cytokines. 
Taken  together,  eATP  signaling  exhibits  a  multi-tiered  influence  on  inflammation  via  innate 
immunity. A confounding question, however, is whether innate and adaptive immunity can be linked 
through eATP signaling and associated ROS production. A recent study of anticancer therapy has 
identified a role for eATP signaling in directing both innate and adaptive immunity. It is well known 
that dying and injured cells release ATP, even during anti-tumor treatments [69]. The present study 
also identified induction of Il-1β secretion from DCs in response to ATP release, resulting in priming 
of interferon-gamma (IFN-γ)-producing lymphocytes.  Thus,  eATP has  effectively created a potent 
anticancer  response,  acting  through  inflammatory  cytokine  signaling  to  stimulate  adaptive 
immunity [70]. Another novel finding linked eATP signaling with antigen presentation to coordinate Int. J. Mol. Sci. 2011, 12                       
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Mycobacterial destruction. eATP and P2X7 coupling has been shown to rapidly induce shedding of 
MHC-II containing exosomes from macrophages as a result of inflammasome activation [71,72]. As 
we  have  mentioned  before,  ROS  secondary  signaling  facilitates  inflammasome  formation  and  
activity [66], thus ROS can mediate both innate and immune responses. The same group expanded 
their studies to include Mycobacterium infection of phagocytes, and found that the released exosomes 
contained MHC-II: Mtb Ag 85B (a Mycobacterial antigen) [73]. The antigen presenting MHCII:Mtb 
Ag 85B complexes were also shown to activate T-lymphocytes [73], thus providing an important 
insight into eATP-P2X7-mediated synergy of innate and adaptive immune responses.  
It is tempting to speculate that innate and adaptive immunity can be linked to operate concurrently 
through eATP mediated ROS production. These mechanisms are likely facilitated by the secondary 
signaling capabilities of ROS, and we have seen clear evidence supporting the role of oxygen radicals 
in immune activation. However, it is important to recognize the highly complex and dynamic nature of 
the immune system, and coordination of both the innate and adaptive immunity is not likely to be 
exclusively limited to eATP purinergic signaling. 
3.2. P2X7 Receptor Activation by eATP Elicits Signaling Cascades through ROS  
Purinergic  receptor  signaling  lately  has  emerged  as  an  important  signaling  pathway  related  to 
various cellular processes. P2X7 has been classically distinguished from the other P2 receptors due to 
the fact that it is a ligand-gated ion channel and it has low-affinity to eATP concentration. Upon eATP 
binding  of  P2X7,  Ca
2+  ions  flow  through  the  pore  formed  in  the  membrane  of  the  cell,  creating  
signal-transducing stimuli. This in turn activates several signaling intermediates, including NADPH 
oxidase  ROS  production,  which  can  operate  to  influence  pro-inflammatory  and  immune  response 
elements, such as cytokine synthesis and transcription factor activation [74–76].  
A large body of evidence suggests that the signaling networks of eATP-P2X7 coupling are in fact 
dependent on ROS production. In 1997, it was discovered in microglial cells that NF-κB, a potent  
pro-inflammatory transcription factor, expression was influenced to a large degree by P2X7 [77]. This 
study also revealed that unlike other NF-κB complex formation resulting from other stimuli, such as 
LPS, ATP specifically stimulated formation of p65 homodimers. More importantly, the same study 
demonstrated that formation of NF-κB was abolished when cells were treated with antioxidants, thus 
providing strong evidence for the necessity of eATP-induced ROS generation for pro-inflammatory 
gene transcription [77].  
Another recently described transcription factor, cyclic-AMP responsive element binding protein 
(CREB), which plays a protective role for cell survival, appears to be important during elevated ROS 
conditions (e.g., oxidative stress). Unlike NF-κB, which is associated with pro-inflammatory cytokine 
production and cell death, CREB protects cells against oxidative stress-induced cell death [78–80]. It 
also seems that eATP-P2X7 coupling can influence the CREB pathway, perhaps offering cells a level 
of protection against oxidative stress-mediated cell death [79,81]. It remains to be seen how CREB 
participates in infection models, but it could provide a level of resistance to cell death in response to 
pathogenic challenge. 
Much like the dualistic nature of ROS molecules themselves, the transcription factors that oxygen 
radicals  influence  can  potentiate  antagonistic  responses  in  cells.  Though  we  have  already  shown Int. J. Mol. Sci. 2011, 12                       
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evidence for microbial modulation of ROS, primarily via NADPH oxidase interference, eATP-P2X7 
coupling can also be a target for microorganisms seeking to alter ROS production for their long term 
carriage.  NADPH  oxidase  complexes  are  now  associated  with  P2X7  signaling  cascades,  thus 
interference  directly  at  this  receptor  could  provide  another  way  for  microbes  to  enhance  survival 
and persistence.  
3.3. eATP-P2X7 Receptor Signaling Mediates Pathogen Killing  
There is a noteworthy amount of research regarding eATP-induced pathogen elimination via the 
P2X7  receptor.  Toxoplasma  gondii,  for  example,  has  been  demonstrated  to  be  eliminated  by  
eATP-P2X7 coupled production of ROS molecules, thus facilitating reduction of parasitic load within 
host  cells  [82]  (Another  study  yielded  similar  results,  however,  this  group  did  not  test  for  ROS 
involvement  in  the  observed  clearance  of  T.  gondii  [83]).  In  these  two  studies,  however,  
T. gondii-infected host cells were subjected to rapid eATP-mediated apoptosis, a response serving to 
likely control extracellular spread of Toxoplasma [82,83]. 
Another  microorganism  that  establishes  chronic  intracellular  infections  and  is  also  subject  to  
P2X7-mediated elimination is M. tuberculosis. Studies of this organism in host cell models clearly 
provide  evidence  of  eATP-P2X7  induced  Mycobacterial  elimination  through  multiple  processes, 
including apoptosis [84], phospholipase-D [85], autophagy [86] and phagosome-lysosome fusion [87]. 
Thus, P2X7 is likely a major contributor against Mycobacterial immunity. In addition, there have been 
numerous  studies  suggesting  that  polymorphisms  in  the  P2X7  gene  may  increase  susceptibility  to 
Mycobacterial infections, demonstrating the importance of functional P2X7 in these pathologies [88–92].  
Chlamydial infections of host cells are also found to be limited by eATP-P2X7 signaling processes. 
eATP-P2X7  stimulation  of  Phospholipase-D  activity  was  shown  to  be  required  to  limit  some 
Chlamydial infections of epithelium and macrophages [93–95]. Taken together, these studies show that 
eATP and P2X7 receptor signaling are important immune response elements to a variety of pathogenic 
infections. However, targeting of eATP-P2X7 coupling could be exhibited by pathogens, and in fact 
there are examples of microbes that exploit this to establish persistence and survival. 
3.4. Subversion of eATP-P2X7 Pathway by Persistent Microbes 
Intracellular  parasites  can  exhibit  selective  pressures  on  the  P2X7  receptor-mediated  signaling 
network, influencing host cell physiology to enhance survival. These effects are likely to be highly 
variable and dependent on multiple factors, including specific invading organism, host tissue type and 
physiology,  environmental  pressures,  and  even  the  presence  of  other  colonizing  organisms.  This 
exploitation  of  eATP  and  the  P2X7-mediated  cell  immune  response  represents  a  fascinating 
mechanism of overcoming host attempts to limit infection.  
Some  evidence  suggests  direct  microbe-mediated  modulation  of  P2X7.  Studies  of  
Chlamydia  psitacci  show  that  the  Ca
2+  signal  resulting  from  eATP-P2X7  coupling  is  diminished, 
resulting in reduced host cell apoptosis [96]. Though we have provided evidence for other organisms 
exhibiting ROS-modulatory effects to promote persistence, this study shows that P2X7 can also be a 
target to promote microbial survival in host tissues.  Int. J. Mol. Sci. 2011, 12                       
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Leishmania  amazonensis  also  has  been  demonstrated  to  interfere  with  eATP-P2X7  mediated 
signaling  and  associated  ROS  generation  [97].  Identification  of  a  multi-functional  ATP  utilizing 
enzyme ecto-Nucleoside diphosphate kinase (Ndk) in this protozoan has been attributed with eATP 
scavenging  capabilities,  reducing  eATP-P2X7  induced  host  cell  death  during  infection  [98]. 
Additionally, the supernatant from M. bovis, an opportunistic pathogen, containing the Ndk protein 
decreases the activity of P2X7 receptor [99].  
Porphyromonas gingivalis, a successful host-adapted pathogen capable of intracellular replication 
and spreading within the host cells, faces the challenge of host-mediated immune responses to clear the 
microorganism and prevent colonization [100–102]. Similarly, P. gingivalis has also been shown to 
exploit  eATP-P2X7  signaling  associated  with  host  cell  death  in  primary  gingival  epithelial  cells 
(GECs) [103]. The organism accomplishes this by secreting an Ndk homologue, which hydrolyses 
eATP, thereby decreasing P2X7 ligation, resulting in the inhibition of GEC cell death. Indeed, current 
studies by our laboratory of P. gingivalis indicate that the bacterium is also capable of modulating the 
cellular  ROS levels  and protecting primary GECs  against eATP-P2X7 induced oxidative-stress  by 
inhibiting the global ROS production upon prolonged infection in the host cells. This effect appears to 
be  mediated  by  both  utilizing  host  NADPH  oxidase  and  mitochondria  associated  oxidative-stress 
pathways  via  time-dependent  secretion  of  P.  gingivalis-Ndk  enzyme  during  the  infection  [104].  
P. gingivalis infection has also been demonstrated to inhibit mitochondrial membrane depolarization, 
cytochrome  c  release,  and  activation  of  caspase  3  and  pro-apoptotic  Bad  through  
pro-survival PI3K/AKT pathway [105–107]. AKT and Extracellular signal-related kinase (ERK) 1 and 
2, members of the mitogen-activated protein kinase (MAPK) network, have been studied in relation to 
P2X7,  revealing  interesting  results.  It  was  shown  that  ERK1/2  activity  during  LPS-stimulation  of 
macrophages could be under control of P2X7 receptor [108,109]. In ovarian cancer cells, cellular ROS 
stimulation was  found  to  be  important  for  signal  cascades,  particularly  for  AKT  and  ERK  [110].  
As  mentioned  earlier,  eATP  was  demonstrated  to  be  required  for  release  of  IL-1β  from  
P. gingivalis-infected GECs [68]. The same study also reported that GECs express functional Nalp3 
inflammasome formation during the P. gingivalis infection, suggesting an additional role for ROS 
secondary signaling in this infection model.  
Whether the ROS production and redox signaling are specifically influenced by the above discussed 
modulatory pathways during P. gingivalis infection remains to be seen. However, it is likely that 
eATP-P2X7 mediated ROS signaling play an important role in the persistent nature of this successful 
opportunist in the epithelial cells. As a model organism, P. gingivalis, a major etiological agent in the 
formation  of  chronic  inflammatory/infectious  diseases  (namely  periodontal  diseases)  could  help 
explain some fundamental properties of chronic conditions associated with host-adapted opportunistic 
microbes, perhaps translating to new insights into other chronic inflammatory pathologies (Figure 1). 
Intriguingly,  a  new  study  illustrated  that  NLRX1  and  NADPH  oxidase  are  both  involved  in 
Chlamydia trachomatis-induced ROS formation. NLRX1 and the ROS formed in the mitochondria 
actually promote the bacterial growth [17]. Depletion of NLRX1 and inhibition of NADPH oxidase 
ROS production attenuated Chlamydial load. In previous studies performed by the same group, it was 
discovered  that  Chlamydial  growth  was  enhanced  by  ROS-mediated  caspase-1  production  via 
inflammasome formation [111]. It now seems that NLRX1 and NADPH oxidase play an important role 
in generating the ROS required to mediate signaling cascades resulting in caspase-1-dependent growth Int. J. Mol. Sci. 2011, 12                       
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of Chlamydia [17]. It is logical to suggest that eATP can act as a physiological mediator for the  
cross-talk that takes place between the two pathways and include an additional layer of complexity in 
the whole host-microbe interaction. 
Figure 1. Proposed mechanisms for modulation of intracellular ROS via P2X7, NADPH 
oxidase,  and  Mitochondrion  Interference.  (A)  Invasive  microorganisms  subvert  with 
NADPH  oxidase-based  ROS  formation  via  interference  of  complex  assembly;  
(B)  Microbial  scavenging  of  ROS  produced  by  NADPH  oxidase;  (C)  Interference  of 
mitochondrion-based  ROS  production  during  infection;  (D)  Modulation  of  eATP-P2X7 
signaling induction by nucleotide scavenging; (E) CREB could be involved in promoting 
host cell survival, and thus may potentiate microbial persistence. 
 
4. Conclusions 
It is quite notable that a number of distantly related intracellular pathogens exhibit similar abilities 
to influence inflammation and immune clearance by modulating eATP-P2X7 derived cellular ROS. 
This novel occurrence appears as a common theme that enhances survival of both the host and the 
invading  microorganism,  and  it  can  be  achieved  through  reduction  of  intracellular  ROS  through 
exploitation  of  host  metabolic  pathways  by  host-adapted  microbes.  More  intriguingly,  successful 
colonizers may also “unwittingly” have come to use physiological ROS signaling properties for their 
own designs including microbial utility of eATP induced ROS as growth signaling molecules. Overall, 
a large amount of recent evidence suggests that a wide array of pathogens have developed various Int. J. Mol. Sci. 2011, 12                       
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complex, yet converging molecular strategies to limit or exacerbate ROS formation in order to subvert 
immune defenses and support self-survival and long term carriage in their target host cells.  
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